Research programme: taxane derivatives - Indena

Drug Profile

Research programme: taxane derivatives - Indena

Alternative Names: IDN 5390; IDN 6140

Latest Information Update: 17 Nov 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Indena
  • Class Paclitaxels; Taxanes
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 24 Oct 2008 Pharmacodynamics data from a preclinical trial in glioma presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (EORTC-NCI-AACR-2008)
  • 06 Nov 2007 Preclinical trials in Cancer in Italy (IV)
  • 06 Nov 2007 Clinical data presented at the 19th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2007) added to the pharmacokinetics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top